PAGLIARO, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 1.444
AS - Asia 1.235
EU - Europa 1.097
SA - Sud America 211
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 74
OC - Oceania 2
Totale 4.140
Nazione #
US - Stati Uniti d'America 1.381
IT - Italia 612
SG - Singapore 414
VN - Vietnam 260
CN - Cina 233
BR - Brasile 150
HK - Hong Kong 90
DE - Germania 89
BD - Bangladesh 78
FR - Francia 63
NL - Olanda 50
ZA - Sudafrica 45
RU - Federazione Russa 43
IE - Irlanda 40
AT - Austria 39
FI - Finlandia 36
CA - Canada 33
IN - India 33
GB - Regno Unito 32
SE - Svezia 27
AR - Argentina 25
IQ - Iraq 19
MX - Messico 18
KR - Corea 14
ID - Indonesia 13
JP - Giappone 13
PL - Polonia 13
BE - Belgio 10
TR - Turchia 10
PK - Pakistan 9
CZ - Repubblica Ceca 8
PH - Filippine 8
EC - Ecuador 7
ES - Italia 7
LT - Lituania 7
UA - Ucraina 7
EG - Egitto 6
PA - Panama 6
CO - Colombia 5
MA - Marocco 5
PY - Paraguay 5
SA - Arabia Saudita 5
UY - Uruguay 5
VE - Venezuela 5
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
IL - Israele 4
PE - Perù 4
TH - Thailandia 4
UZ - Uzbekistan 4
DZ - Algeria 3
GR - Grecia 3
KE - Kenya 3
MY - Malesia 3
PT - Portogallo 3
TW - Taiwan 3
AU - Australia 2
CL - Cile 2
HR - Croazia 2
JM - Giamaica 2
LY - Libia 2
NI - Nicaragua 2
NP - Nepal 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BO - Bolivia 1
CY - Cipro 1
ET - Etiopia 1
GF - Guiana Francese 1
GP - Guadalupe 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TN - Tunisia 1
Totale 4.063
Città #
Ashburn 269
Singapore 242
San Jose 176
Parma 162
Dallas 124
Santa Clara 114
Hong Kong 85
Council Bluffs 82
Ho Chi Minh City 82
Boardman 70
Milan 62
Hanoi 50
New York 47
Beijing 46
Johannesburg 42
Munich 42
Dublin 40
Bologna 39
Los Angeles 38
Ann Arbor 33
Vienna 33
Lauterbourg 30
Rome 28
Chandler 27
Shanghai 26
São Paulo 24
Chicago 21
Buffalo 20
Reggio Emilia 20
Turku 20
Hefei 19
Brescia 18
Haiphong 17
Modena 17
Moscow 17
Nuremberg 14
Toronto 13
Frankfurt am Main 12
Helsinki 12
Amsterdam 11
Biên Hòa 10
Brooklyn 10
Jakarta 10
Montreal 10
Fidenza 9
Seoul 9
Tokyo 9
Warsaw 9
Brussels 8
Carpi 8
Curitiba 8
Perugia 8
Turin 8
West Jordan 8
Baghdad 7
London 7
Columbus 6
Mexico City 6
Orem 6
Phoenix 6
Rio de Janeiro 6
Boston 5
Chandigarh 5
Da Nang 5
Denver 5
Florence 5
Lahore 5
Naples 5
Poplar 5
San Francisco 5
Seattle 5
Abidjan 4
Atlanta 4
Baku 4
Brasília 4
Bremen 4
Brno 4
Cairo 4
Charlotte 4
Chennai 4
Concesio 4
Istanbul 4
Nanjing 4
Paris 4
Princeton 4
Querétaro 4
Quito 4
Roubaix 4
Salvador 4
Tashkent 4
Bengaluru 3
Buenos Aires 3
Cape Town 3
Casalgrande 3
City of London 3
Guangzhou 3
Houston 3
Inglewood 3
Jeddah 3
Kochi 3
Totale 2.568
Nome #
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line 263
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 262
Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis 235
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 231
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity 210
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 190
Targeting oncogenic Notch signaling with SERCA inhibitors 188
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 161
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 159
Targeting Notch Trafficking and Processing in Cancers 149
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 148
Acute lymphoblastic leukaemia 142
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 140
SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL 137
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 136
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 131
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia 123
PROGNOSTIC VALUE OF CYTOGENETIC ABERRATIONS AND INTRATUMORAL GENETIC HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 118
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 110
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 102
FROM GENOMICS TO CHEMOGEGNOMICS IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA 99
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: From current standards to precision medicine 95
IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA 92
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 84
Ex-vivo drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with PICALM::MLLT10 80
A chemotrascriptomic screening identifies the reversal of glucocorticoid resistance in NOTCH1 mutated T-ALL. 77
Nidogen-1, a Player in KMT2A-Rearranged Pediatric Acute Myeloid Leukemia 70
EHMT2/G9A drives the epigenetic regulation of glucose metabolism in T-cell Acute lymphoblastic leukemia 61
Drug profiling in a preclinical murine mantle cell lymphoma mouse model identifies novel vulnerabilities. 56
Targeting oncogenic NOTCH1 in T-cell acute lymphoblastic leukemia with a new selective serca inhibitor. 48
Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia 19
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia 11
Targeting Oncogenic NOTCH1 in T-cell Acute Lymphoblastic Leukemia With a Selective SERCA Inhibitor CAD204520 9
Multicenter real-life evaluation of the Post-CAR prognostic index for patients with large B-cell lymphoma after CAR-T failure 4
Totale 4.140
Categoria #
all - tutte 13.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202248 0 4 6 4 3 4 11 3 1 3 2 7
2022/2023166 8 19 12 11 31 14 5 7 36 2 17 4
2023/2024259 8 3 4 15 5 18 70 22 14 33 17 50
2024/2025956 33 37 55 81 84 73 77 71 105 71 98 171
2025/20262.383 192 137 271 271 313 148 180 150 307 205 111 98
2026/2027206 84 122 0 0 0 0 0 0 0 0 0 0
Totale 4.140